68Ga-DOTATATE在良性前列腺增生中的摄取
68Ga-DOTATATE in Benign Prostate Hyperplasia.
PubMed 文献 · Clin Nucl Med · 2019-01-01
一例79岁男性类癌综合征患者,活检确诊为高分化神经内分泌肿瘤,68Ga-DOTATATE PET/CT显示双肺多发结节、左肺门淋巴结及前列腺弥漫性摄取增高。患者前列腺特异性抗原升高,但前列腺活检未发现前列腺癌,仅显示良性前列腺增生。
要点
- 68Ga-DOTATATE PET/CT可显示良性前列腺增生的弥漫性摄取增高。
- 前列腺良性增生可表现为DOTATATE摄取,需与肿瘤性病变鉴别。
- 前列腺特异性抗原升高伴DOTATATE前列腺摄取时,活检有助于排除前列腺癌。
核心结论
- 良性前列腺增生可表现为68Ga-DOTATATE弥漫性摄取增高,并非肿瘤特异性表现。
研究设计与样本
- 单例病例报告:79岁男性类癌综合征患者,双肺结节活检确诊高分化神经内分泌肿瘤,行68Ga-DOTATATE PET/CT检查。
主要发现
- 68Ga-DOTATATE PET/CT显示双肺多发摄取增高结节、左肺门淋巴结及前列腺弥漫性摄取增高。
关键数值与推荐
- 患者前列腺特异性抗原水平升高,但前列腺活检未发现前列腺癌,仅显示良性前列腺增生。
临床怎么用
- 判读68Ga-DOTATATE PET/CT前列腺弥漫性摄取时,应结合前列腺特异性抗原及活检结果,考虑良性前列腺增生可能。
局限性
- 单例病例报告,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 79-year-old man had carcinoid syndrome and bilateral pulmonary nodules, which were biopsy confirmed as well-differentiated neuroendocrine tumor. PET/CT with Ga-[DOTA-Tyr]-octreotate (Ga-DOTATATE) showed multiple Ga-DOTATATE-avid bilateral pulmonary nodules, left hilar lymph node, as well as diffuse increased Ga-DOTATATE uptake in the prostate. A review of the history revealed that this patient had elevated prostate-specific antigen level. The prostate biopsy did not reveal evidence of prostate cancer but showed benign prostate hyperplasia.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Wang J. 68Ga-DOTATATE in Benign Prostate Hyperplasia. Clin Nucl Med. 2019. PMID: 30624277. doi:10.1097/RLU.0000000000002454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。